retatrutide trials Phase 2 Trial of for Obesity A new clinical trial from

Cell Commun Signal

January 2nd, 2025: Ozempic lawsuit reaches 1,331 cases as gastroparesis claims continue to mount The Ozempic Lawsuit centers on claims that the diabetes and weight loss medication Ozempic has led to severe gastrointestinal side effects, including gastroparesis, nausea, and vomiting

Blood pressure, heart rate, cholesterol, blood sugar, waist circumference, sleep quality, inflammation, and fitness level all matter

Ghosal, S., Myers, B., & Herman, J

Persistent nausea that interferes with hydration, nutrition, or daily function should be discussed with a healthcare professional rather than assumed to be a normal adjustment symptom

Among these, triple agonists targeting GLP-1, GIP, and glucagon receptors represent a promising next step